Overview
Organized by DIA and CoRE
Scientific breakthroughs, growing amounts of healthcare data and globalization hold great promises for better health outcomes for patients in need.
Data analytics, real-world evidence, remote clinical monitoring, connected health records, electronic labeling and mobile health apps are among some of the trending topics that will shape the healthcare landscape in the coming years.
Alongside the advances in scientific understanding and health product development overall, paradigm shifts in regulatory processes and global convergence are important for greater synergy among all to bring forth timely innovation benefits to patients and consumers and patients that will improve health outcomes.
Program Committee
-
Dorothee Grimald, PharmD Director, Global Regulatory Policy
Merck Sharp & Dohme (MSD), Germany -
James Leong, PhD, MPharm Head,Health Products & Regulatory Science Centre of Regulatory Excellence (CoRE)
Duke NUS Medical School, Singapore -
Finny Liu, MSc, RPh APAC Regional Regulatory Policy Lead
Roche, Singapore -
Mei Ding JAPAC Regional Lead, Policy & Intelligence
Abbvie Pte. Ltd., Singapore -
Khairul Faizi Khalid, MD Head of Business Development
Clinical Research Malaysia, Malaysia -
Thean Soo Lo Regulatory Affairs Management Consultant
TS Consulting, Singapore -
Shun Jin, MBA Head – BD & RA
PharmaGend Global Medical Services Pte Ltd, Singapore -
Jing Ping Yeo, PhD, MBA Vice President, Clinical Operations & Head, Asia Pacific Precision for Medicine
Precision for Medicine, Singapore -
Kum Cheun Wong, PharmD Head Asia Pacific Regulatory & Development Policy
Novartis Asia Pacific Pharmaceuticals Pte. Ltd., Singapore -
Lars Nelleman, MD, MPharm Founder and Owner
Lars Nelleman Consulting, Singapore -
Fengyun (Vicky) Han Senior Director, Head of Regulatory Policy for Asia Pacific
Johnson & Johnson Pte. Ltd., Singapore
Have an account?
